Advertisement
Kevin Fitzpatrick named CEO of CancerLinQ

Kevin Fitzpatrick named CEO of CancerLinQ

By Modern Healthcare  |  July 11, 2015

Effective Aug. 3, Kevin Fitzpatrick will become CEO of CancerLinQ, a not-for-profit subsidiary of the American Society of Clinical Oncology.

Celgene pays $1B to enter collaboration with Juno Therapeutics

By Steven Ross Johnson  |  June 30, 2015

Leading biotech firm Celgene Corp. will pay $1 billion to enter into a 10-year collaboration with Juno Therapeutics. The move broadens the company's cancer drug portfolio by gaining access to Juno's budding pipeline of oncology immunotherapies.

Cost, value of treatments for common cancers compared

Cost, value of treatments for common cancers compared

By Sabriya Rice  |  June 22, 2015

A new tool will allow oncologists to compare various drug treatments for four common cancers based on survival, side effects and costs. The framework is part of a broader effort to help physicians and patients choose appropriate therapies amid the skyrocketing costs of cancer drugs.

North Shore-LIJ inks deal to create new cancer research center

North Shore-LIJ inks deal to create new cancer research center

By Andis Robeznieks  |  April 02, 2015

North Shore-Long Island Jewish Health System and Cold Spring Harbor (N.Y.) Laboratory have agreed on a $120 million “joint, long-term investment,” much of which will be used to create a new clinical cancer research unit at the system's Cancer Institute in Lake Success, N.Y.

U.S. cancer care faces key challenges as country ages

By Steven Ross Johnson  |  March 18, 2015

Cancer care in the U.S. faces a number of challenges involving care access, delivery and cost, despite making medical strides that resulted in a record number of cancer survivors in 2014, a new report finds.

Advertisement
Modern Healthcare Daily

Award winning coverage of healthcare business and policy news.

The Modern Healthcare app includes a personalized home screen, strong search functionality and immediate downloads from the industry's leading healthcare media brand.